Skip to main content
. 2020 Jan 2;5(2):209–215. doi: 10.1001/jamacardio.2019.4759

Figure 2. Potential Evidence-Based Prevention of Major Cardiovascular Events and All-Cause Deaths by Each Trial.

Figure 2.

A, Potential prevention of events in patients with ischemic heart disease at baseline. B, Potential prevention of events in patients with prior myocardial infarction. Based on patients from the Copenhagen General Population Study. Major cardiovascular (CV) events is the composite end point of myocardial infarction, stroke, and cardiovascular death.